About Us

Aptagen, LLC is a biotechnology and life-sciences company.  We are a global leader in developing ‘synthetic antibodies’ called aptamers, with over 30 years of experience.  Aptamers are target-recognition elements with high affinity and specificity against targets such as small molecules, protein biomarkers, cells, and tissues. Aptamers are an alternative platform to that of antibodies for diagnostic, therapeutic, and bio-industrial applications.

Explore below to learn more about how aptamers can help you!

Aptamers vs Antibodies - Low cost to Produce, No Batch-to-Batch Variation
Biomarker Discovery
Cell-Tissue Targeting & Imaging
Drug Discovery & Delivery
See the Apta-Beacon Difference
NextGen Aptamers